|
🐢
|
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
19 auth.
P. Wen,
D. R. MacDonald,
D. Reardon,
T. Cloughesy,
A. Sorensen,
E. Galanis,
J. Degroot,
W. Wick,
M. Gilbert,
A. Lassman,
...
C. Tsien,
T. Mikkelsen,
Eric T. Wong,
M. Chamberlain,
R. Stupp,
K. Lamborn,
M. Vogelbaum,
M. J. van den Bent,
Susan M. Chang
|
11 |
2010 |
11
🐢
|
|
🐜
|
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
36 auth.
J. Eckel-Passow,
D. Lachance,
A. Molinaro,
K. Walsh,
P. Decker,
H. Sicotte,
M. Pekmezci,
T. Rice,
M. Kosel,
I. Smirnov,
G. Sarkar,
Alissa A. Caron,
T. Kollmeyer,
Corinne E. Praska,
A. Chada,
...
C. Halder,
H. Hansen,
L. McCoy,
P. Bracci,
Roxanne E Marshall,
S. Zheng,
G. Reis,
Alexander R. Pico,
B. O'neill,
J. Buckner,
C. Giannini,
J. Huse,
A. Perry,
T. Tihan,
M. Berger,
Susan M. Chang,
M. Prados,
J. Wiemels,
J. Wiencke,
M. Wrensch,
R. Jenkins
|
10 |
2015 |
10
🐜
|
|
🐜
|
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
10 auth.
Justin S. Smith,
E. Chang,
K. Lamborn,
Susan M. Chang,
M. Prados,
S. Cha,
...
T. Tihan,
S. Vandenberg,
M. McDermott,
M. Berger
|
10 |
2008 |
10
🐜
|
|
🐜
|
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
34 auth.
Brett E. Johnson,
T. Mazor,
C. Hong,
Michael R. Barnes,
Koki Aihara,
Cory Y. McLean,
S. Fouse,
Shogo Yamamoto,
H. Ueda,
K. Tatsuno,
S. Asthana,
L. Jalbert,
S. Nelson,
A. Bollen,
W. Gustafson,
...
E. Charron,
W. Weiss,
I. Smirnov,
Jun S. Song,
A. Olshen,
S. Cha,
Yongjun Zhao,
Richard A. Moore,
A. Mungall,
Steven J. M. Jones,
M. Hirst,
M. Marra,
N. Saito,
H. Aburatani,
A. Mukasa,
M. Berger,
Susan M. Chang,
B. Taylor,
J. Costello
|
10 |
2014 |
10
🐜
|
|
🐜
|
Response assessment criteria for brain metastases: proposal from the RANO group.
27 auth.
N. Lin,
E. Lee,
H. Aoyama,
I. Barani,
D. Barboriak,
B. Baumert,
M. Bendszus,
P. Brown,
D. Camidge,
Susan M. Chang,
J. Dancey,
E. D. Vries,
L. Gaspar,
G. Harris,
F. Hodi,
...
S. Kalkanis,
M. Linskey,
M. Linskey,
D. Macdonald,
K. Margolin,
M. Mehta,
D. Schiff,
R. Soffietti,
J. Suh,
M. Bent,
M. Vogelbaum,
P. Wen
|
9 |
2015 |
9
🐜
|
|
🐜
|
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
40 auth.
P. Wen,
M. Weller,
E. Lee,
B. Alexander,
J. Barnholtz-Sloan,
F. Barthel,
T. Batchelor,
R. Bindra,
Susan M. Chang,
E. Chiocca,
T. Cloughesy,
J. Degroot,
E. Galanis,
M. Gilbert,
M. Hegi,
...
C. Horbinski,
Raymond Y Huang,
A. Lassman,
É. Le Rhun,
M. Lim,
M. Mehta,
I. Mellinghoff,
G. Minniti,
D. Nathanson,
M. Plattén,
M. Preusser,
P. Roth,
M. Sanson,
D. Schiff,
S. Short,
M. Taphoorn,
J. Tonn,
J. Tsang,
R. Verhaak,
A. von Deimling,
W. Wick,
G. Zadeh,
D. Reardon,
K. Aldape,
M. J. van den Bent
|
9 |
2020 |
9
🐜
|
|
🐢
|
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
12 auth.
E. Laws,
I. Parney,
Wei Huang,
F. Anderson,
A. M. Morris,
A. Asher,
...
K. Lillehei,
M. Bernstein,
H. Brem,
A. Sloan,
M. Berger,
Susan M. Chang
|
9 |
2003 |
9
🐢
|
|
🐜
|
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
16 auth.
W. Yung,
M. Prados,
R. Yaya-tur,
S. Rosenfeld,
M. Brada,
H. Friedman,
R. Albright,
J. Olson,
Susan M. Chang,
A. O'Neill,
...
A. Friedman,
J. Bruner,
N. Yue,
M. Dugan,
S. Zaknoen,
V. Levin
|
9 |
1999 |
9
🐜
|
|
🐜
|
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.
28 auth.
B. Ellingson,
M. Bendszus,
J. Boxerman,
D. Barboriak,
B. Erickson,
M. Smits,
S. Nelson,
E. Gerstner,
B. Alexander,
G. Goldmacher,
W. Wick,
M. Vogelbaum,
M. Weller,
E. Galanis,
Jayashree Kalpathy-Cramer,
...
L. Shankar,
P. Jacobs,
W. Pope,
Dewen Yang,
C. Chung,
M. Knopp,
S. Cha,
M. J. van den Bent,
Susan M. Chang,
W. Yung,
T. Cloughesy,
P. Wen,
M. Gilbert
|
9 |
2015 |
9
🐜
|
|
🐜
|
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
19 auth.
M. Bent,
J. Wefel,
D. Schiff,
M. Taphoorn,
K. Jaeckle,
L. Junck,
T. Armstrong,
T. Armstrong,
A. Choucair,
A. Waldman,
...
T. Gorlia,
M. Chamberlain,
B. Baumert,
M. Vogelbaum,
D. R. MacDonald,
D. Reardon,
P. Wen,
Susan M. Chang,
A. Jacobs
|
9 |
2011 |
9
🐜
|
|
🐜
|
Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility
28 auth.
M. Wrensch,
R. Jenkins,
Jeffrey S. Chang,
R. Yeh,
Yuanyuan Xiao,
K. Ballman,
M. Berger,
J. Buckner,
Susan M. Chang,
P. Decker,
C. Giannini,
C. Halder,
T. Kollmeyer,
M. Kosel,
D. Lachance,
...
L. McCoy,
Brian B. O'Neill,
Joe Patoka,
Alexander R. Pico,
M. Prados,
C. Quesenberry,
T. Rice,
Amanda L. Rynearson,
I. Smirnov,
T. Tihan,
J. Wiemels,
Ping Yang,
J. Wiencke
|
9 |
2009 |
9
🐜
|
|
🐬
|
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.
K. Lamborn,
Susan M. Chang,
M. Prados
|
8 |
2004 |
8
🐬
|
|
🐜
|
Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
7 auth.
Edward F. Chang,
M. Potts,
G. Keles,
K. Lamborn,
Susan M. Chang,
N. Barbaro,
...
Mitchel S. Berger
|
8 |
2008 |
8
🐜
|
